Science Explorer Interactive view Map
Company · Tokyo · Japan

SBI Pharmaceuticals (Japan)

sbipharma.co.jp/englishROR OpenAlex
World rank, all time
#37,490
of 42,892
Rank in Japan
#1,689
of 2,112
Research works
129
▲ 22% vs 2013–17
Citations
2.3k
17.7 per fractional work
Top-10% rate
10.3%
record average 16.5%
Open access
52%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.33× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.14× its world share, 5 worksBiochemistry, Geneti…Immunology and Microbiology: 8.29× its world share, 2 worksImmunology and Micro…Neuroscience: 1.74× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.93× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.81× its world share, 0 worksChemistryComputer Science: 0.71× its world share, 2 worksComputer ScienceEarth and Planetary Sciences: 0.17× its world share, 0 worksEarth and Planetary …Engineering: 0.56× its world share, 3 worksEngineeringEnvironmental Science: 0.91× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.57× its world share, 1 worksMaterials SciencePhysics and Astronomy: 0.66× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.26× its world share, 0 worksHealth ProfessionsMedicine: 2.21× its world share, 13 worksMedicineNursing: 0.45× its world share, 0 worksNursingBusiness, Management and Accounting: 0.40× its world share, 0 worksBusiness, Management…Decision Sciences: 0.57× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.31× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.07× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 8.3×. Every wedge is a field page.

Who are the top researchers at SBI Pharmaceuticals (Japan)?

Ranked on the composite score, Motowo Nakajima, Tohru Tanaka and Masahiro Ishizuka lead among researchers whose main affiliation is SBI Pharmaceuticals (Japan).

  1. 1 Motowo Nakajima Japan · #227,112 worldwide 186 citations · 56 works
  2. 2 Tohru Tanaka Japan · #836,918 worldwide 42 citations · 35 works
  3. 3 Masahiro Ishizuka Japan · #1,361,985 worldwide 7 citations · 19 works
All ranked researchers at SBI Pharmaceuticals (Japan)

Which keywords describe research at SBI Pharmaceuticals (Japan)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Oxidative Stress, Reactive Oxygen Species, Photodynamic Therapy, Antimicrobial, Inflammation, Nanoparticles, Cancer Treatment and Immunosuppression.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 22 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 22 words, with their numbers
  1. Oxidative Stress3▲ 6.4×12 topics
  2. Inflammation2▲ 3.5×13 topics
  3. Reactive Oxygen Species2▲ 17×5 topics
  4. Nanoparticles2▲ 4.8×4 topics
  5. Epidemiology2▲ 1.39×11 topics
  6. Photodynamic Therapy2▲ 26×3 topics
  7. Antimicrobial2▲ 19×2 topics
  8. Cancer Treatment1▲ 20×3 topics
  9. Immunosuppression1▲ 49×3 topics
  10. Immunotherapy1▲ 5.9×5 topics
  11. Photosensitizers1▲ 190×1 topic
  12. Singlet Oxygen1▲ 190×1 topic
  13. Gene Therapy1▲ 18×2 topics
  14. Immunity1▲ 9.0×4 topics
  15. Vitamin B121▲ 104×2 topics
  16. Apoptosis1▲ 11×7 topics
  17. Biosimilars1▲ 165×1 topic
  18. Cancer1▲ 2.5×7 topics
  19. Immunogenicity1▲ 76×1 topic
  20. Lead Exposure1▲ 101×1 topic
  21. Metal Toxicity1▲ 55×1 topic
  22. Monoclonal Antibodies1▲ 38×2 topics

Which research topics does SBI Pharmaceuticals (Japan) publish most on?

By volume in 2022–2025: Photodynamic Therapy Research Studies, Heavy Metal Exposure and Toxicity, Biosimilars and Bioanalytical Methods and Virus-based gene therapy research.

Photodynamic Therapy Research Studies: 1 fractional worksHeavy Metal Exposure and Toxicity: 1 fractional worksBiosimilars and Bioanaly…1Biosimilars and Bioanalytical Methods: 1 fractional worksVirus-based gene therapy…1Virus-based gene therapy research: 1 fractional worksPorphyrin Metabolism and Disorders: 1 fractional worksSkin Protection and Aging: 1 fractional worksHeme Oxygenase-1 and Car…0Heme Oxygenase-1 and Carbon Monoxide: 0 fractional worksFolate and B Vitamins Re…0Folate and B Vitamins Research: 0 fractional worksViral-associated cancers…0Viral-associated cancers and disorders: 0 fractional worksPolyomavirus and related…0Polyomavirus and related diseases: 0 fractional works
Pulmonary and Respiratory MedicineHealth, Toxicology and MutagenesisImmunologyGenetics4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Photodynamic Therapy Research Studies Pulmonary and Respiratory Medicine 1 works
  2. 2 Heavy Metal Exposure and Toxicity Health, Toxicology and Mutagenesis 1 works
  3. 3 Biosimilars and Bioanalytical Methods Immunology 1 works
  4. 4 Virus-based gene therapy research Genetics 1 works
  5. 5 Porphyrin Metabolism and Disorders Molecular Biology 1 works
  6. 6 Skin Protection and Aging Dermatology 1 works
  7. 7 Heme Oxygenase-1 and Carbon Monoxide Molecular Biology 0 works
  8. 8 Folate and B Vitamins Research Rheumatology 0 works
  9. 9 Viral-associated cancers and disorders Oncology 0 works
  10. 10 Polyomavirus and related diseases Oncology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available52.4%not open47.6%

World: 28% of research is openly available.

with international co-authors17.1%domestic only82.9%

World: 19% is written across borders.

How has SBI Pharmaceuticals (Japan)'s research output changed?

Output in 2018–2022 was 22% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Tokyo

All research institutions in Tokyo

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.